Great find gimme greenbacks! I dug down that sam
Post# of 8405
(Total Views: 579)
Posted On: 03/19/2019 11:04:23 AM
Great find gimme greenbacks!
I dug down that same hole you found out of curiosity.
Looks like Keith Nalepka, VP Marketing & Sales knows what he's doing.
http://www.cvsactipatch.com
http://www.walgreensactipatch.com
http://www.drschollsactipatch.com
http://www.usaactipatch.com
I'm still left wondering about senior management though. There’s a lot of nagging talk about Whelan and Dr. Scholls and CVS out there and about other opportunities maybe missed. I made some calls to pain product buyers at retail head offices and the answers aren’t adding up. Hard to know what’s what.
Keith Nalepka, Sales & Marketing and Sree Koneru on the science both totally know what they are doing. Just listen to their interviews and presentations. Crisp and focused, professional, technically sound and all business.
But, an aging CEO, who is also the only director of a publicly traded company? Who in their right mind these days would place themselves in that kind of personal jeopardy to shareholder litigation if something were to go sideways? No one. Listen to Whelan’s interviews and compare them to Nalepka’s. No comparison. Whelan should take credit and be proud he hired him, did a great job in front of the mike.
Company needs a dynamic leader and a proper, real (not stacking it with family and friends), 5 or 6 person board of experienced people who can guide the company forward respecting good governance and fiduciary duty. It would also help in raising capital to be able to present a properly structured company to potential investors instead of a one trick pony show. Time for BIEL to raise the bar of senior management.
Whelan has done a masterful job of managing this start-up for 15 years or so of struggle, FDA, pickpockets, charlatans etc., but he just got his wings badly clipped, therefor ours too, by the SEC, a large personal fine, or are shareholders expected to pay that one, and five years banned from dealing in public companies and their shares. How does that help shareholders? It hurts is what it does. Credit where it is due, but it’s time to reboot this company into the 21st century. Whelan maybe should retain his role as Chairman, if he still has the energy, and do what’s best for shareholders who are $30 million in the hole, or is hanging on about ego? I hope not. Does anyone know Whelan? Not a bash, just constructive thinking.
I dug down that same hole you found out of curiosity.
Looks like Keith Nalepka, VP Marketing & Sales knows what he's doing.
http://www.cvsactipatch.com
http://www.walgreensactipatch.com
http://www.drschollsactipatch.com
http://www.usaactipatch.com
I'm still left wondering about senior management though. There’s a lot of nagging talk about Whelan and Dr. Scholls and CVS out there and about other opportunities maybe missed. I made some calls to pain product buyers at retail head offices and the answers aren’t adding up. Hard to know what’s what.
Keith Nalepka, Sales & Marketing and Sree Koneru on the science both totally know what they are doing. Just listen to their interviews and presentations. Crisp and focused, professional, technically sound and all business.
But, an aging CEO, who is also the only director of a publicly traded company? Who in their right mind these days would place themselves in that kind of personal jeopardy to shareholder litigation if something were to go sideways? No one. Listen to Whelan’s interviews and compare them to Nalepka’s. No comparison. Whelan should take credit and be proud he hired him, did a great job in front of the mike.
Company needs a dynamic leader and a proper, real (not stacking it with family and friends), 5 or 6 person board of experienced people who can guide the company forward respecting good governance and fiduciary duty. It would also help in raising capital to be able to present a properly structured company to potential investors instead of a one trick pony show. Time for BIEL to raise the bar of senior management.
Whelan has done a masterful job of managing this start-up for 15 years or so of struggle, FDA, pickpockets, charlatans etc., but he just got his wings badly clipped, therefor ours too, by the SEC, a large personal fine, or are shareholders expected to pay that one, and five years banned from dealing in public companies and their shares. How does that help shareholders? It hurts is what it does. Credit where it is due, but it’s time to reboot this company into the 21st century. Whelan maybe should retain his role as Chairman, if he still has the energy, and do what’s best for shareholders who are $30 million in the hole, or is hanging on about ego? I hope not. Does anyone know Whelan? Not a bash, just constructive thinking.
(1)
(0)